| | Other Issues: previous | next | latest | archiveMethodology High correlation of the proteome patterns in bone marrow and peripheral blood blast cells in patients with acute myeloid leukemia Gero Hütter, Anne Letsch, Daniel Nowak, Julia Poland, Pranav Sinha, Eckhard Thiel, and Wolf-K Hofmann PMCID: PMC2630935 Research Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients Jun-ichi Kobayashi, Toshihiko Torigoe, Yoshihiko Hirohashi, Satomi Idenoue, Akihiro Miyazaki, Akira Yamaguchi, Hiroyoshi Hiratsuka, and Noriyuki Sato PMCID: PMC2627828 Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma Howard L Kaufman, Bret Taback, William Sherman, Dae Won Kim, William H Shingler, Dorota Moroziewicz, Gail DeRaffele, Josephine Mitcham, Miles W Carroll, Richard Harrop, Stuart Naylor, and Seunghee Kim-Schulze PMCID: PMC2631474 Semi-allogeneic vaccines and tumor-induced immune tolerance Jin Yu, Mark S Kindy, and Sebastiano Gattoni-Celli PMCID: PMC2631475 Can urinary exosomes act as treatment response markers in prostate cancer? Paul J Mitchell, Joanne Welton, John Staffurth, Jacquelyn Court, Malcolm D Mason, Zsuzsanna Tabi, and Aled Clayton PMCID: PMC2631476 Angiostatin anti-angiogenesis requires IL-12: The innate immune system as a key target Adriana Albini, Claudio Brigati, Agostina Ventura, Girieca Lorusso, Marta Pinter, Monica Morini, Alessandra Mancino, Antonio Sica, and Douglas M Noonan PMCID: PMC2630934 |
